• Presentation

Lapatinib plus capecitabine versus capecitabine alone for metastatic breast cancer: Quality-adjusted Time Without Symptoms or Toxicity (Q-TWiST)

Citation

Sherrill, B. H., Allshouse, A. A., Amonkar, M. M., & Stein, S. H. (2007, May). Lapatinib plus capecitabine versus capecitabine alone for metastatic breast cancer: Quality-adjusted Time Without Symptoms or Toxicity (Q-TWiST). Presented at 43rd American Society of Clinical Oncology (ASCO) Annual Meeting, .

Abstract